Report sounds alarm about Brexit risks to UK clinical trials environment
The Fitch Solutions report, released this week, notes that the number of clinical trials taking place in the UK has already fallen more than 25 percent.
The Fitch Solutions report, released this week, notes that the number of clinical trials taking place in the UK has already fallen more than 25 percent.
Negotiations with country-level reimbursement authorities will follow. The UK's NICE turned down Gilead's Yescarta Tuesday.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
European Medicines Agency faces greater loss of staff than anticipated, forcing it to scale back or suspend some activities.
Santa Monica, California-based Kite Pharma has jumped the Atlantic to file the first Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for a CAR-T therapy.